XML 30 R20.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Summary of Significant Accounting Policies (Tables)
3 Months Ended
Mar. 31, 2024
Summary of Significant Accounting Policies  
Schedule of anti-dilutive common stock equivalents excluded from the calculation of diluted net loss per share

Three Months Ended March 31,

    

2024

    

2023

Common stock warrants

6,796,280

1,031,820

Stock options

 

6,052,298

 

2,562,234

Series X Preferred Stock

 

5,184,591

 

5,184,591

18,033,169

8,778,645

Schedule of condensed consolidated statement of cash flows

The reconciliation of cash, cash equivalents and restricted cash reported within the applicable condensed consolidated balance sheet that sum to the total of the same such amount shown in the condensed consolidated statement of cash flows is as follows (in thousands):

March 31, 

    

2024

    

2023

Cash and cash equivalents

$

172,012

$

202,301

Restricted cash

163

163

Total

$

172,175

$

202,464